Important Pharmacogenetic Information for Drugs Prescribed During the SARS‐CoV‐2 Infection (COVID‐19)

In December 2019, the severe acute respiratory syndrome virus‐2 pandemic began, causing the coronavirus disease 2019. A vast variety of drugs is being used off‐label as potential therapies. Many of the repurposed drugs have clinical pharmacogenetic guidelines available with therapeutic recommendatio...

Full description

Saved in:
Bibliographic Details
Published inClinical and Translational Science Vol. 13; no. 6; pp. 1023 - 1033
Main Authors Zubiaur, Pablo, Koller, Dora, Saiz‐Rodríguez, Miriam, Navares‐Gómez, Marcos, Abad‐Santos, Francisco
Format Journal Article Web Resource
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.11.2020
John Wiley and Sons Inc
Subjects
Adenosine Monophosphate - analogs & derivatives
Adenosine Monophosphate - therapeutic use
Alanine - analogs & derivatives
Alanine - therapeutic use
Angiotensin-Converting Enzyme 2 - physiology
Antiviral Agents - therapeutic use
Biomarkers
Chloroquine - therapeutic use
Clinical medicine
Clinical trials
Coronaviruses
COVID-19
COVID-19 Drug Treatment
Cytochrome
Cytokines
Dehydrogenases
Disease
Drug dosages
Epidemics
Humans
Hydroxychloroquine - therapeutic use
Pandemics
Pharmacogenetics
Prescription drugs
Review
Reviews
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Europe
Online AccessGet full text

Cover

More Information
Summary:In December 2019, the severe acute respiratory syndrome virus‐2 pandemic began, causing the coronavirus disease 2019. A vast variety of drugs is being used off‐label as potential therapies. Many of the repurposed drugs have clinical pharmacogenetic guidelines available with therapeutic recommendations when prescribed as indicated on the drug label. The aim of this review is to provide a comprehensive summary of pharmacogenetic biomarkers available for these drugs, which may help to prescribe them more safely.
Bibliography:These authors contributed equally for to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1752-8054
1752-8062
1752-8062
DOI:10.1111/cts.12866